Transcranial Magnetic Stimulation: A Scoping Review
DOI:
https://doi.org/10.14738/assrj.1304.20215Keywords:
Transcranial Magnetic Stimulation, Dementia, Alzheimer’s Disease, Neurocognitive Disorders, Cognitive Rehabilitation, Neuroimaging, Scoping Review, NeuromodulationAbstract
Background: Transcranial magnetic stimulation (TMS) has gained increasing recognition as a non-invasive neuromodulatory technique with potential therapeutic applications in dementia and related neurocognitive disorders. This scoping review examined the literature from 1985 through 2023 to evaluate how TMS has been applied across dementia subtypes, which forms of stimulation and neuroimaging techniques have been most frequently used, and what cognitive outcomes have been observed. Method: A systematic search of PubMed, PsycArticles, and PsycInfo yielded 184 articles, of which a subset met inclusion criteria requiring the application of TMS alongside neuropsychological testing. Results: The results demonstrated a striking predominance of Alzheimer’s disease, which accounted for nearly three-quarters of included studies, while vascular dementia, frontotemporal dementia, and Lewy body dementia were rarely addressed. Neuroimaging integration was limited, with the majority of studies not incorporating it; when applied, EEG, MRI, and fMRI were most frequently paired with TMS. Cognitive outcomes were overwhelmingly positive, with 52.9% of studies reporting strong improvements and 44.1% reporting very strong improvements in standardized neuropsychological measures. Notably, no study reported null or adverse effects. Repetitive TMS emerged as the most widely used modality, followed by high-frequency rTMS, whereas deep TMS, low-frequency rTMS, intermittent theta burst stimulation, and bifocal TMS were applied only sporadically. Chi-square analyses revealed no significant associations between dementia type and TMS form or between dementia type and cognitive outcomes, suggesting that observed benefits may generalize across diagnostic subgroups. Discussion: The findings indicate that TMS may enhance cognitive function in dementia regardless of subtype or stimulation protocol, though methodological inconsistencies and limited neuroimaging integration restrict interpretability. Conclusion: TMS appears to be a robust and reproducible intervention for enhancing cognition in dementia, but standardized protocols and larger.
References
A. T. Barker, R. Jalinous, and I. L. Freeston, “Non-invasive magnetic stimulation of human motor cortex,” Lancet Lond. Engl., vol. 1, no. 8437, pp. 1106–1107, May 1985, doi: 10.1016/s0140-6736(85)92413-4.
M. Hallett, “Transcranial magnetic stimulation: a primer,” Neuron, vol. 55, no. 2, pp. 187–199, July 2007, doi: 10.1016/j.neuron.2007.06.026.
S. Rossi et al., “Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines,” Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol., vol. 132, no. 1, pp. 269–306, Jan. 2021, doi: 10.1016/j.clinph.2020.10.003.
S. K. Mann and N. K. Malhi, “Repetitive Transcranial Magnetic Stimulation,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Oct. 31, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK568715/
J.-P. Lefaucheur et al., “Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018),” Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol., vol. 131, no. 2, pp. 474–528, Feb. 2020, doi: 10.1016/j.clinph.2019.11.002.
S. Vucic and M. C. Kiernan, “Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease,” Neurother. J. Am. Soc. Exp. Neurother., vol. 14, no. 1, pp. 91–106, Jan. 2017, doi: 10.1007/s13311-016-0487-6. Page | 277 Scholar Publishing
J. Antczak, G. Rusin, and A. Słowik, “Transcranial Magnetic Stimulation as a Diagnostic and Therapeutic Tool in Various Types of Dementia,” J. Clin. Med., vol. 10, no. 13, p. 2875, June 2021, doi: 10.3390/jcm10132875.
G. Koch, A. Martorana, and C. Caltagirone, “Transcranial magnetic stimulation: Emerging biomarkers and novel therapeutics in Alzheimer’s disease,” Neurosci. Lett., vol. 719, p. 134355, Feb. 2020, doi: 10.1016/j.neulet.2019.134355.
N. Lapitskaya, M. R. Coleman, J. F. Nielsen, O. Gosseries, and A. M. de Noordhout, “Disorders of consciousness: further pathophysiological insights using motor cortex transcranial magnetic stimulation,” Prog. Brain Res., vol. 177, pp. 191–200, 2009, doi: 10.1016/S0079-6123(09)17713-0.
A. Jannati, L. M. Oberman, A. Rotenberg, and A. Pascual-Leone, “Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation,” Neuropsychopharmacology, vol. 48, no. 1, pp. 191–208, Jan. 2023, doi: 10.1038/s41386-022-01453-8.
Y.-H. Chou, M. Sundman, V. Ton That, J. Green, and C. Trapani, “Cortical excitability and plasticity in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies,” Ageing Res. Rev., vol. 79, p. 101660, Aug. 2022, doi: 10.1016/j.arr.2022.101660.
C. V. Turco, J. El-Sayes, M. J. Savoie, H. J. Fassett, M. B. Locke, and A. J. Nelson, “Shortand long-latency afferent inhibition; uses, mechanisms and influencing factors,” Brain Stimulat., vol. 11, no. 1, pp. 59–74, 2018, doi: 10.1016/j.brs.2017.09.009.
B. Zhang, X. Luo, Y. Ning, J. Wang, and Y.-F. Zang, “Editorial: Investigating the Mechanism of TMS Using Brain Imaging Methods,” Front. Neurosci., vol. 16, p. 936219, 2022, doi: 10.3389/fnins.2022.936219.
W. M. van der Flier and P. Scheltens, “Epidemiology and risk factors of dementia,” J. Neurol. Neurosurg. Psychiatry, vol. 76 Suppl 5, no. Suppl 5, pp. v2-7, Dec. 2005, doi: 10.1136/jnnp.2005.082867.
M. Weiler, K. C. Stieger, J. M. Long, and P. R. Rapp, “Transcranial Magnetic Stimulation in Alzheimer’s Disease: Are We Ready?,” eNeuro, vol. 7, no. 1, p. ENEURO.0235-19.2019, 2020, doi: 10.1523/ENEURO.0235-19.2019.
G. C. Román, “Stroke, Cognitive Decline and Vascular Dementia: The Silent Epidemic of the 21st Century,” Neuroepidemiology, vol. 22, no. 3, pp. 161–164, Apr. 2003, doi: 10.1159/000069885.
M. M. Corrada, R. Brookmeyer, A. Paganini-Hill, D. Berlau, and C. H. Kawas, “Dementia incidence continues to increase with age in the oldest old: the 90+ study,” Ann. Neurol., vol. 67, no. 1, pp. 114–121, Jan. 2010, doi: 10.1002/ana.21915.
E. Nichols et al., “Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019,” Lancet Public Health, vol. 7, no. 2, pp. e105–e125, Feb. 2022, doi: 10.1016/S2468-2667(21)00249-8.
C. A. Derby, “Trends in the public health significance, definitions of disease, and implications for prevention of Alzheimer’s disease,” Curr. Epidemiol. Rep., vol. 7, no. 2, pp. 68–76, June 2020, doi: 10.1007/s40471-020-00231-8.
M. A. Rouse, R. J. Binney, K. Patterson, J. B. Rowe, and M. A. Lambon Ralph, “A neuroanatomical and cognitive model of impaired social behaviour in frontotemporal dementia,” Brain, vol. 147, no. 6, pp. 1953–1966, June 2024, doi: 10.1093/brain/awae040.
I. Khan and O. De Jesus, “Frontotemporal Lobe Dementia,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Nov. 02, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK559286/Page | 278 Scholar Publishing
Kai Sin Chin, “Pathophysiology of dementia,” Aust. J. Gen. Pract., vol. 52, no. 8, Aug. 2023, doi: 10.31128/AJGP-02-23-6736.
C. Dang et al., “Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis,” Front. Pharmacol., vol. 15, Aug. 2024, doi: 10.3389/fphar.2024.1451032.
N. S. Rost et al., “Post-Stroke Cognitive Impairment and Dementia,” Circ. Res., vol. 130, no. 8, pp. 1252–1271, Apr. 2022, doi: 10.1161/CIRCRESAHA.122.319951.
M. M. F. Poels et al., “Cerebral microbleeds are associated with worse cognitive function,” Neurology, vol. 78, no. 5, pp. 326–333, Jan. 2012, doi: 10.1212/WNL.0b013e3182452928.
E. Demeter, J. L. Mirdamadi, S. K. Meehan, and S. F. Taylor, “Short theta burst stimulation to left frontal cortex prior to encoding enhances subsequent recognition memory,” Cogn. Affect. Behav. Neurosci., vol. 16, no. 4, pp. 724–735, Aug. 2016, doi: 10.3758/s13415-016-0426-3.
Y. Huang et al., “Theta-burst direct electrical stimulation remodels human brain networks,” Nat. Commun., vol. 15, no. 1, p. 6982, Aug. 2024, doi: 10.1038/s41467-024-51443-1.
M. Cantone et al., “The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia,” Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol.,
G. Tesco and S. Lomoio, “Pathophysiology of neurodegenerative diseases: an interplay among axonal transport failure, oxidative stress, and inflammation?,” Semin. Immunol., vol. 59, p. 101628, Jan. 2022, doi: 10.1016/j.smim.2022.101628.
D. A. Spampinato, J. Ibanez, L. Rocchi, and J. Rothwell, “Motor potentials evoked by transcranial magnetic stimulation: interpreting a simple measure of a complex system,” J. Physiol., vol. 601, no. 14, pp. 2827–2851, 2023, doi: 10.1113/JP281885.
V. Di Lazzaro et al., “Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia,” Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol.,
G. M. D. Feo, M. Emond, and K. Ghassemkhani, “Dementia and its Relations Between the Late 20th and 21st Century,” Adv. Soc. Sci. Res. J., vol. 10, no. 7, pp. 129–141, July 2023, doi: 10.14738/assrj.107.15071.
P. D. Sloane et al., “The public health impact of Alzheimer’s disease, 2000-2050: potential implication of treatment advances,” Annu. Rev. Public Health, vol. 23, pp. 213–231, 2002, doi: 10.1146/annurev.publhealth.23.100901.140525.
J. Keene, T. Hope, C. G. Fairburn, and R. Jacoby, “Death and dementia,” Int. J. Geriatr. Psychiatry, vol. 16, no. 10, pp. 969–974, 2001, doi: 10.1002/gps.474.
E. C. Caparelli, T. Zhai, and Y. Yang, “Simultaneous Transcranial Magnetic Stimulation and Functional Magnetic Resonance Imaging: Aspects of Technical Implementation,” Front. Neurosci., vol. 14, Sept. 2020, doi: 10.3389/fnins.2020.554714.
K. P. Ebmeier, “Transcranial magnetic stimulation and neuroimaging,” Bipolar Disord., vol. 4 Suppl 1, pp. 96–97, 2002, doi: 10.1034/j.1399-5618.4.s1.42.x.
L. Aceves-Serrano, J. L. Neva, and D. J. Doudet, “Insight Into the Effects of Clinical Repetitive Transcranial Magnetic Stimulation on the Brain From Positron Emission Tomography and Magnetic Resonance Imaging Studies: A Narrative Review,” Front. Neurosci., vol. 16, Feb. 2022, doi: 10.3389/fnins.2022.787403.
D. J. Oathes et al., “Combining transcranial magnetic stimulation with functional magnetic resonance imaging for probing and modulating neural circuits relevant to affective Page | 279 Scholar Publishing disorders,” Wiley Interdiscip. Rev. Cogn. Sci., vol. 12, no. 4, p. e1553, July 2021, doi: 10.1002/wcs.1553.
J. Jung, A. Bungert, R. Bowtell, and S. R. Jackson, “Vertex Stimulation as a Control Site for Transcranial Magnetic Stimulation: A Concurrent TMS/fMRI Study,” Brain Stimulat., vol. 9, no. 1, pp. 58–64, Jan. 2016, doi: 10.1016/j.brs.2015.09.008.
A. Senczyszyn et al., “Improvement of working memory in older adults with mild cognitive impairment after repetitive transcranial magnetic stimulation – a randomized controlled pilot study,” Front. Psychiatry, vol. 14, Nov. 2023, doi: 10.3389/fpsyt.2023.1196478.
J. Yang, R. Liang, L. Wang, C. Zheng, X. Xiao, and D. Ming, “Repetitive Transcranial Magnetic Stimulation (rTMS) Improves the Gait Disorders of Rats Under Simulated Microgravity Conditions Associated With the Regulation of Motor Cortex,” Front. Physiol., vol. 12, p. 587515, 2021, doi: 10.3389/fphys.2021.587515.
C.-M. Cheng, C.-T. Li, and S.-J. Tsai, “Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression,” Adv. Exp. Med. Biol., vol. 1305, pp. 333–349, 2021, doi: 10.1007/978-981-33-6044-0_18.
M. J. Page et al., “The PRISMA 2020 statement: an updated guideline for reporting systematic reviews,” Syst. Rev., vol. 10, no. 1, p. 89, Mar. 2021, doi: 10.1186/s13643-021-01626-4. Page | 280
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gian Di Feo, Fahdlullahi Adeniran, Kobe Gannon-Day, Anthony Zanetti, Micheal Emond, Kassra Ghassemkhani
This work is licensed under a Creative Commons Attribution 4.0 International License.
